These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1283 related articles for article (PubMed ID: 24355873)

  • 21. Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study.
    Tampieri A; Giovannini E; Rusconi AM; Cristoni L; Bendanti D; Cenni P; Lenzi T
    Intern Emerg Med; 2015 Mar; 10(2):181-92. PubMed ID: 25430677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of small vessel disease in re-exacerbation of stroke symptoms within 24 hours after tissue plasminogen activator infusion.
    Uemura J; Kimura K; Inoue T; Shibazaki K; Sakamoto Y; Aoki J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):75-9. PubMed ID: 23153551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator.
    Pfeilschifter W; Kashefiolasl S; Lauer A; Steinmetz H; Foerch C
    Neuroscience; 2013 Oct; 250():181-8. PubMed ID: 23856067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukoaraiosis and lacunes are associated with poor clinical outcomes in ischemic stroke patients treated with intravenous thrombolysis.
    Arba F; Palumbo V; Boulanger JM; Pracucci G; Inzitari D; Buchan AM; Hill MD;
    Int J Stroke; 2016 Jan; 11(1):62-7. PubMed ID: 26763021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracerebral hemorrhage after thrombolytic therapy in acute ischemic stroke patients with renal dysfunction.
    Chao TH; Lin TC; Shieh Y; Chang TY; Hung KL; Liu CH; Lee TH; Chang YJ; Lee JD; Chang CH
    Eur Neurol; 2013; 70(5-6):316-21. PubMed ID: 24080988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-analysis.
    Charidimou A; Kakar P; Fox Z; Werring DJ
    J Neurol Neurosurg Psychiatry; 2013 Mar; 84(3):277-80. PubMed ID: 23024352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update.
    Derex L; Nighoghossian N
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1093-9. PubMed ID: 18223014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline characteristic of patients presenting with lacunar stroke and cerebral small vessel disease may predict future development of depression.
    Pavlovic AM; Pekmezovic T; Zidverc Trajkovic J; Svabic Medjedovic T; Veselinovic N; Radojicic A; Mijajlovic M; Tomic G; Jovanovic Z; Norton M; Sternic N
    Int J Geriatr Psychiatry; 2016 Jan; 31(1):58-65. PubMed ID: 25821003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemorrhagic complications after systemic thrombolysis in acute stroke patients with abnormal baseline coagulation.
    Brunner F; Tomandl B; Schröter A; Mellinghoff C; Haldenwanger A; Hildebrandt H; Kastrup A
    Eur J Neurol; 2011 Dec; 18(12):1407-11. PubMed ID: 21672089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Number of cerebral microbleeds and risk of intracerebral hemorrhage after intravenous thrombolysis.
    Dannenberg S; Scheitz JF; Rozanski M; Erdur H; Brunecker P; Werring DJ; Fiebach JB; Nolte CH
    Stroke; 2014 Oct; 45(10):2900-5. PubMed ID: 25116882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany.
    Audebert HJ; Kukla C; Vatankhah B; Gotzler B; Schenkel J; Hofer S; Fürst A; Haberl RL
    Stroke; 2006 Jul; 37(7):1822-7. PubMed ID: 16763192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
    Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
    J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral Small Vessel Disease in Standard Pre-operative Imaging Reports Is Independently Associated with Increased Risk of Cardiovascular Death Following Carotid Endarterectomy.
    Timmerman N; Rots ML; van Koeverden ID; Haitjema S; van Laarhoven CJHCM; Vuurens AM; den Ruijter HM; Pasterkamp G; Kappelle LJ; de Kleijn DPV; de Borst GJ
    Eur J Vasc Endovasc Surg; 2020 Jun; 59(6):872-880. PubMed ID: 32331995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial.
    Barow E; Boutitie F; Cheng B; Cho TH; Ebinger M; Endres M; Fiebach JB; Fiehler J; Ford I; Galinovic I; Nickel A; Puig J; Roy P; Wouters A; Magnus T; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G;
    JAMA Neurol; 2019 Jun; 76(6):641-649. PubMed ID: 30907934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of suitability of thrombolysis in middle cerebral artery infarction: a proof of concept study of a stereologically-based technique.
    Phan TG; Donnan GA; Koga M; Mitchell LA; Molan M; Fitt G; Chong W; Holt M; Reutens DC
    Cerebrovasc Dis; 2007; 24(4):321-7. PubMed ID: 17690543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.